B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics.
Felten R, Duret PM, Bauer E, Sedmak N, Djossou JH, Bensalem M, Ardizzone M, Geoffroy M, Fan A, Couderc M, Salmon JH, Messer L, Javier RM, Meyer A, Chatelus E, Sordet C, Pijnenburg L, Fort J, Rinagel M, Walther J, Fabre C, Arnaud L, Sibilia J, Meyer N, Berenbaum F, Chary-Valckenaere I, Soubrier M, Sellam J, Gottenberg JE.
Felten R, et al. Among authors: bensalem m.
Ann Rheum Dis. 2022 Jan;81(1):143-145. doi: 10.1136/annrheumdis-2021-220549. Epub 2021 Sep 23.
Ann Rheum Dis. 2022.
PMID: 34556483
No abstract available.